Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

Lung cancer is the most common cancer for men and women in Hawaii and in recent years, the state has ranked last in the ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

GP practices who order more chest X-rays have fewer patients with cancers diagnosed at a late stage, researchers have found.

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

The Repetitive Saliva Swallowing Test, or RSST, is a simple, non-invasive screening tool for oropharyngeal dysphagia, which causes difficulty swallowing, where patients are asked to swallow saliva as ...

Onvida Health is bringing a new era of precision and early detection to lung cancer care in Yuma. The hospital has introduced ...

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...